Tosufloxacin hydrochloride

CAS No. 104051-69-6

Tosufloxacin hydrochloride ( A-61827 hydrochloride; T-3262 hydrochloride )

Catalog No. M23249 CAS No. 104051-69-6

Tosufloxacin hydrochloride is a fluoroquinolone antibacterial agent used to treat bacterial infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 41 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tosufloxacin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Tosufloxacin hydrochloride is a fluoroquinolone antibacterial agent used to treat bacterial infections.
  • Description
    Tosufloxacin hydrochloride is a fluoroquinolone antibacterial agent used to treat bacterial infections.Tosufloxacin hydrochloride is also a bacterial Topo (DNA gyrase, topoisomerase)) inhibitor.
  • Synonyms
    A-61827 hydrochloride; T-3262 hydrochloride
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    bacterial DNA gyrase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    104051-69-6
  • Formula Weight
    440.8
  • Molecular Formula
    C19H16ClF3N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    FC1=CC(F)=C(N2C=C(C(O)=O)C(C3=C2N=C(N4CCC(N)C4)C(F)=C3)=O)C=C1.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li T , Wang J , Cao Q , et al. Identification of Novel Genes Involved in Escherichia coli Persistence to Tosufloxacin[J]. Frontiers in Cellular and Infection Microbiology, 2020, 10:581986.
molnova catalog
related products
  • Cefotiam hydrochlori...

    Cefotiam hydrochloride is a second-generation cephalosporin antibiotic, has broad-spectrum activity against Gram-positive and Gram-negative bacteria.

  • QcrB inhibitor TB47

    QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.

  • Moxifloxacin

    A fourth-generation synthetic fluoroquinolone, broad-spectrum antibacterial agent that is active against both Gram-positive and Gram-negative bacteria.